ASTS vs NBIX · rev $4.4M vs P/E 45, rev $2.36B
Ast Spacemobile Inc (ASTS) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Ast Spacemobile Inc (ASTS) is a communication equipment company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ASTS revenue for 2024-12-31 was $4.4M. Net income was -$526.3M. ASTS currently screens at market cap $33.16B.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ASTS currently screens at market cap $33.16B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ASTS and NBIX stock pages for the full models.
Not investment advice.